HUTCHMED (China) (HCM) EBIT (2016 - 2021)
Historic EBIT for HUTCHMED (China) (HCM) over the last 6 years, with Q4 2021 value amounting to -$252.5 million.
- HUTCHMED (China)'s EBIT changed N/A to -$252.5 million in Q4 2021 from the same period last year, while for Dec 2021 it was $176.2 million, marking a year-over-year change of. This contributed to the annual value of -$43.7 million for FY2024, which is 12682.25% down from last year.
- Latest data reveals that HUTCHMED (China) reported EBIT of -$252.5 million as of Q4 2021.
- HUTCHMED (China)'s EBIT's 5-year high stood at $220.6 million during Q1 2021, with a 5-year trough of -$252.5 million in Q4 2021.
- Moreover, its 4-year median value for EBIT was -$5.1 million (2018), whereas its average is -$5.2 million.
- As far as peak fluctuations go, HUTCHMED (China)'s EBIT plummeted by 34304.17% in 2019, and later surged by 26903.74% in 2020.
- Quarter analysis of 4 years shows HUTCHMED (China)'s EBIT stood at -$161.1 million in 2018, then skyrocketed by 76.14% to -$38.4 million in 2019, then soared by 295.36% to $75.1 million in 2020, then tumbled by 436.23% to -$252.5 million in 2021.
- Its EBIT stands at -$252.5 million for Q4 2021, versus $220.6 million for Q1 2021 and $75.1 million for Q2 2020.